
Patients with peripheral zzso disease zzso are at increased risk of generalized zzso zzso zzso data shows a high rate of zzso of zzso and zzso in other vascular zzso zzso zzso modification and zzso therapy has become the cornerstone of treatment to prevent zzso events associated with zzso Recent clinical trials have confirmed the clinical benefit of zzso and zzso in patients with zzso agents that zzso inhibit the binding of zzso zzso to its zzso zzso In the zzso versus aspirin in patients at risk of zzso events zzso trial, zzso was associated with an overall risk reduction of zzso zzso with zzso zzso in zzso zzso zzso zzso stroke and vascular zzso These results demonstrated that long-term administration of zzso was effective in preventing zzso events in patients with zzso vascular disease including zzso Aspirin and/or zzso are the zzso agents of choice for the reduction of zzso events in patients with zzso 

